Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that it will present at the TD Cowen 45th Annual Health Care Conference in Boston, MA, on…
AgTech Company accelerates strategic focus on Industrial Hemp Carbon Credits business Hempalta Corp. (TSXV: HEMP) (‘Hempalta’ or the ‘Company’)…
Invion Limited (ASX: IVX) (“Invion” or the “Company”) is pleased to announce that it has successfully completed a new…
Red Mountain Mining Limited (“RMX” or the “Company”) is pleased to advise that today it will commence conducting a…
Quimbaya Gold Inc. (CSE: QIM) (OTCQB: QIMGF) (FSE: K05) (‘Quimbaya Gold’ or the ‘Company’) is pleased to announce that,…
(TheNewswire) March 3, 2025 TheNewswire – Drilling at La Soledad, has intercepted multiple high-grade veins as the Target 1…
American West Metals Limited (American West Metals or the Company) (ASX:AW1) is pleased to announce positive findings of the…
Market volatility was on full display this week, beginning with a sharp selloff on Monday (February 24) and exacerbated…
Here’s a quick recap of the crypto landscape for Friday (February 28) as of 9:00 p.m. UTC. Bitcoin and…